Founder of seven companies, Christopher presently serves as President & CEO of both Fedora Pharmaceuticals Inc. and Brass Dome Ventures Ltd. Fedora Pharmaceuticals Inc. is an anti-infective drug discovery company founded in 2011. In 2014, Fedora signed the largest licensing deal ever signed in Canadian biotech history, licensing their beta-lactamase inhibitor to Hoffman J La Roche for US$750 million in addition to royalties. Fedora continues the pursuit of developing new drugs that save lives. Brass Dome Ventures Ltd. was founded in 2016 and employs a multi-disciplinary team of business experts offering business management and consulting services.
Christopher is also a Founder of Innovation Masterminds Edmonton (imYEG), a pre-accelerator program designed to help Alberta post-secondary innovators advance their innovations to market. In addition, Christopher serves as General Partner of BFO (Brass Fund One) a venture fund established to provide both financing and critical business support to accepted ventures.